195 related articles for article (PubMed ID: 22232281)
1. Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
Dahyot S; Mammeri H
Antimicrob Agents Chemother; 2012 Mar; 56(3):1151-6. PubMed ID: 22232281
[TBL] [Abstract][Full Text] [Related]
2. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
Ahmed AM; Shimamoto T
Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases.
Mammeri H; Guillon H; Eb F; Nordmann P
Antimicrob Agents Chemother; 2010 Nov; 54(11):4556-60. PubMed ID: 20733047
[TBL] [Abstract][Full Text] [Related]
5. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G
FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650
[TBL] [Abstract][Full Text] [Related]
6. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
Mammeri H; Nazic H; Naas T; Poirel L; Léotard S; Nordmann P
Antimicrob Agents Chemother; 2004 Oct; 48(10):4050-3. PubMed ID: 15388478
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.
Rodríguez-Martínez JM; Fernández-Echauri P; Fernández-Cuenca F; Diaz de Alba P; Briales A; Pascual A
J Antimicrob Chemother; 2012 Jan; 67(1):64-8. PubMed ID: 22001269
[TBL] [Abstract][Full Text] [Related]
8. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
Mammeri H; Poirel L; Nordmann P
J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
[TBL] [Abstract][Full Text] [Related]
9. Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC beta-lactamase.
Barlow M; Hall BG
Genetics; 2003 May; 164(1):23-9. PubMed ID: 12750318
[TBL] [Abstract][Full Text] [Related]
10. Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.
Endimiani A; Doi Y; Bethel CR; Taracila M; Adams-Haduch JM; O'Keefe A; Hujer AM; Paterson DL; Skalweit MJ; Page MG; Drawz SM; Bonomo RA
Biochemistry; 2010 Feb; 49(5):1014-23. PubMed ID: 19938877
[TBL] [Abstract][Full Text] [Related]
11. LMB-1 producing Citrobacter freundii from Argentina, a novel player in the field of MBLs.
Dabos L; Rodriguez CH; Nastro M; Dortet L; Bonnin RA; Famiglietti A; Iorga BI; Vay C; Naas T
Int J Antimicrob Agents; 2020 Feb; 55(2):105857. PubMed ID: 31785341
[TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum cephalosporinase in Acinetobacter baumannii.
Rodríguez-Martínez JM; Nordmann P; Ronco E; Poirel L
Antimicrob Agents Chemother; 2010 Aug; 54(8):3484-8. PubMed ID: 20547808
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.
Shaheen BW; Nayak R; Foley SL; Kweon O; Deck J; Park M; Rafii F; Boothe DM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5666-75. PubMed ID: 21947397
[TBL] [Abstract][Full Text] [Related]
14. Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamase.
Dahyot S; Broutin I; de Champs C; Guillon H; Mammeri H
FEMS Microbiol Lett; 2013 Aug; 345(2):147-53. PubMed ID: 23763375
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of extended-spectrum-β-lactamase-producing and plasmid-mediated AmpC β-lactamase-producing Escherichia coli isolated from stray dogs in South Korea.
Tamang MD; Nam HM; Jang GC; Kim SR; Chae MH; Jung SC; Byun JW; Park YH; Lim SK
Antimicrob Agents Chemother; 2012 May; 56(5):2705-12. PubMed ID: 22354297
[TBL] [Abstract][Full Text] [Related]
16. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate.
Mammeri H; Poirel L; Bemer P; Drugeon H; Nordmann P
Antimicrob Agents Chemother; 2004 Mar; 48(3):716-20. PubMed ID: 14982755
[TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
[TBL] [Abstract][Full Text] [Related]
18. Identification of CFE-2, a new plasmid-encoded AmpC β-lactamase from a clinical isolate of Citrobacter freundii.
Chen CM; Huang M; Wu HJ; Guo MK; Wu LT
Int J Antimicrob Agents; 2018 Sep; 52(3):421-424. PubMed ID: 29944954
[TBL] [Abstract][Full Text] [Related]
19. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
20. Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.
Gazouli M; Tzouvelekis LS; Vatopoulos AC; Tzelepi E
J Antimicrob Chemother; 1998 Oct; 42(4):419-25. PubMed ID: 9818739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
